FDA Inspection 1027456 — Luosun (Shanghai) Bio-Tech Co., Ltd
The FDA completed an inspection of Luosun (Shanghai) Bio-Tech Co., Ltd on July 21, 2017 in Shanghai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 21, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shanghai (China)